| For: | Chai SY, Zhang RY, Ning ZY, Zheng YM, Swapnil R, Ji LN. Sodium-glucose co-transporter 2 inhibitors improve insulin resistance and β-cell function in type 2 diabetes: A meta-analysis. World J Diabetes 2025; 16(7): 107335 [PMID: 40697602 DOI: 10.4239/wjd.v16.i7.107335] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i7/107335.htm |
| Number | Citing Articles |
| 1 |
Serafino Fazio, Flora Affuso. Insulin Resistance/Hyperinsulinemia Should Be Considered in the Prevention and Treatment of Essential Hypertension. Biomedicines 2025; 13(12): 3102 doi: 10.3390/biomedicines13123102
|
| 2 |
Charlotte Delrue, Reinhart Speeckaert, Marijn M. Speeckaert. Rewinding the Clock: Emerging Pharmacological Strategies for Human Anti-Aging Therapy. International Journal of Molecular Sciences 2025; 26(19): 9372 doi: 10.3390/ijms26199372
|
| 3 |
Gaurab Bhaduri, Supratik Bhattacharyya, Shatavisa Mukherjee, Rutul Gokalani. Decoupling weight loss from organoprotective benefits in GLP-1RA, dual agonists, and SGLT2I therapy: A narrative review. Acta Diabetologica 2026; doi: 10.1007/s00592-025-02636-7
|
